Evolent Health, Inc $EVH Shares Purchased by GSA Capital Partners LLP

GSA Capital Partners LLP raised its stake in Evolent Health, Inc (NYSE:EVH) by 1,715.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 308,149 shares of the technology company’s stock after purchasing an additional 291,173 shares during the period. GSA Capital Partners LLP owned 0.28% of Evolent Health worth $1,233,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Tejara Capital Ltd purchased a new position in Evolent Health in the fourth quarter valued at approximately $5,326,000. Rock Point Advisors LLC increased its stake in Evolent Health by 21.6% in the fourth quarter. Rock Point Advisors LLC now owns 1,190,156 shares of the technology company’s stock valued at $4,761,000 after purchasing an additional 211,707 shares during the last quarter. Citizens Financial Group Inc. RI increased its stake in Evolent Health by 483.3% in the fourth quarter. Citizens Financial Group Inc. RI now owns 124,177 shares of the technology company’s stock valued at $497,000 after purchasing an additional 102,889 shares during the last quarter. Wealthfront Advisers LLC purchased a new position in Evolent Health in the fourth quarter valued at approximately $80,000. Finally, Evergreen Capital Management LLC purchased a new position in Evolent Health in the fourth quarter valued at approximately $70,000.

Evolent Health Stock Performance

Shares of EVH opened at $3.87 on Thursday. The company’s 50 day simple moving average is $3.06 and its 200-day simple moving average is $3.57. Evolent Health, Inc has a 12-month low of $2.10 and a 12-month high of $12.06. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 2.46. The firm has a market cap of $434.74 million, a PE ratio of -0.81 and a beta of 0.83.

Evolent Health (NYSE:EVH) last posted its quarterly earnings data on Thursday, May 7th. The technology company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.03. Evolent Health had a negative net margin of 26.29% and a positive return on equity of 0.36%. The firm had revenue of $496.25 million for the quarter, compared to analyst estimates of $534.00 million. During the same period last year, the firm posted $0.06 EPS. Evolent Health’s quarterly revenue was up 2.6% on a year-over-year basis. As a group, equities analysts predict that Evolent Health, Inc will post -0.23 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Truist Financial dropped their price target on shares of Evolent Health from $10.00 to $6.00 and set a “buy” rating on the stock in a research note on Wednesday, February 25th. BMO Capital Markets reiterated an “outperform” rating and issued a $3.50 price target on shares of Evolent Health in a research note on Wednesday, February 25th. TD Cowen reiterated a “buy” rating on shares of Evolent Health in a research note on Monday, March 2nd. UBS Group dropped their price target on shares of Evolent Health from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, BTIG Research lowered their target price on shares of Evolent Health from $10.00 to $8.00 and set a “buy” rating on the stock in a research report on Wednesday, February 25th. Thirteen equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $6.00.

Evolent Health Profile

Evolent Health, Inc is a U.S.-based healthcare technology and services company that partners with health systems, physician organizations and health plans to design, build and operate value-based care programs. Headquartered in Arlington, Virginia, the company was founded in 2011 as a joint venture between TPG and the University of Pittsburgh Medical Center (UPMC). Evolent Health aims to help its clients transition from fee-for-service payment models to value-based care arrangements by leveraging its proprietary technology platforms and clinical expertise.

The company’s core offerings include care management solutions, population health analytics and clinical advisory services.